Edition:
United Kingdom

People: Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

2.35USD
23 Aug 2019
Change (% chg)

$0.11 (+4.91%)
Prev Close
$2.24
Open
$2.22
Day's High
$2.35
Day's Low
$2.20
Volume
2,358
Avg. Vol
7,394
52-wk High
$11.17
52-wk Low
$1.71

Guerin, Mark 

Mr. Mark Guerin has been appointed as Chief Financial Officer of the Company, effective September 1, 2016. He has served as Vice President — Financial Planning & Accounting, and Chief Accounting Officer since May 2014, and as Vice President — Financial Planning & Accounting from September 2013 to May 2014. Between January 2012 and September 2013, Mr. Guerin was self-employed as a financial and accounting consultant. For more than six years, through December 2011, Mr. Guerin was employed by CardioKine, Inc., serving as Chief Financial Officer from mid-2009 through December 2011.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --